Power3 Medical Products, Inc. (PWRM)
Alzheimer's disease eventually affects all aspects of a person's life: how he or she thinks, feels and acts. Since individuals are affected differently, it is difficult to predict the symptoms each person will have, the order in which they will appear, or the speed of the disease's progression.
In general the following will gradually be affected by the disease:
Mental abilities - A person's ability to understand, think, remember and communicate will be affected. The ability to make decisions will be reduced. Simple tasks that have been performed for years will become more difficult or be forgotten. Confusion and memory loss, initially for recent events and eventually for long-term events, will occur. The ability to find the right words and follow a conversation will be affected.
Emotions and moods - A person may appear uninterested and apathetic, and may quickly lose interest in the hobbies they previously enjoyed. The ability to control mood and emotion may be lost. Some individuals are less expressive and are more withdrawn. However, it is now becoming clear that a person even in the later stages of the disease may continue to feel joy, anger, fear, love, and sadness.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.
Power 3 Medical Products' BC-SeraPro is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients.
Power3 Medical Products, Inc. (PWRM) announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroProÂ®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
For more information please visit official website of PWRM: http://www.power3medical.com
International Speedway Corp. (Nasdaq:ISCA) announced that President John Saunders and Senior Vice President and Chief Financial Officer Dan Houser will address attendees at the Wells Fargo Securities Consumer, Gaming and Lodging Conference on Tuesday, May 24, 2011 at 2:05 p.m. to 2:35 p.m. Eastern Time. In conjunction with this appearance, ISC's conference presentation will be broadcast live on the Internet. Listeners will need to register at the following web address: http://cc.talkpoint.com/well001/052411a_cy/?entity=10_7T7GSLF. Listeners should access the site at least 15 minutes prior to the event start time to register and, if necessary, download and install the required software.
International Speedway Corporation, together with its subsidiaries, promotes motorsports themed entertainment activities in the United States. It conducts racing events at its motorsports entertainment facilities.
Cleantech Transit Inc. (CLNO)
Biomass resources are utilized since millennia for meeting myriad human needs including energy needs. Main supplies of biomass energy are trees, crops and animal waste. Until the middle of 19th century, biomass dominated the global energy supply with a seventy percent share.
Among the biomass energy sources, wood fuels are the most prominent. With rapid increase in fossil fuel use, the share of biomass in total energy declined steadily through substitution by coal in the nineteenth century and later by refined oil and gas during the twentieth century. Despite its declining share in energy, global consumption of wood energy has continued to grow.
Technological advancement in biomass energy is derived from two spheres - biomass energy production practices and energy conversion technologies. Technological advancements in biomass energy conversion comes from three sources - enhanced efficiency of biomass energy conversion technologies, improved fuel processing technologies and enhanced efficiency of end-use technologies.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net).
Mr. Alexander Holtermann CEO Cleantech Transit Inc, who is based in Hong Kong, has worked within the financial markets across Europe for the past seventeen years, involved in the PR and Marketing industry. His career in this industry commenced in PR for the Frankfurt Stock Exchange. He focused on the introduction of junior and senior North American and International public companies to the German-speaking media and financial institutions.
Since 2005 he has been specializing on the Asian public markets, focusing on Hong Kong by establishing personal investment contacts and giving advice to public companies worldwide. He has served as a director on the boards of multiple public companies. Since 1999, he has also served as the Honorary Consul of Belize.
For more information please visit official website of CLNO: http://www.cleantechtransit.com\
CHS Inc. (Nasdaq:CHSCP) announced it has sold its shares in Multigrain S.A., a Brazilian joint venture company with PMG Trading and Mitsui & Co., Ltd., to Mitsui & Co., Ltd., Japan. "As CHS continues to develop and expand its global capabilities and footprint in agriculture and energy commodities, we are now considering a number of our own business projects and investments in South America," said Mark Palmquist, executive vice president and chief operating officer, Ag Business. "We will continue to add shareholder value as we grow our grain origination, logistics, transportation and export capabilities in Brazil."
B Communications Ltd (Nasdaq:BCOM) reported its financial results for the first quarter of 2011 and its cash position and loan repayment status as of March 31, 2011. Progress in B Communications' Loan Repayment Plan. As of March 31, 2011, B Communications had exceeded its original plan for repaying the debt it incurred to fund its April 2010 acquisition of the controlling interest (approximately 30%) in Bezeq - The Israel Telecommunication Corp., Ltd. ("Bezeq"). From April 14, 2010 through March 31, 2011, the Company repaid NIS 892 million (US$ 256 million) of principal and paid NIS 143 million (US$ 41 million) in interest and CPI-linked expenses. During the second quarter of 2011, the Company intends to repay an additional NIS 520 million (US$ 149 million) of its debt.
B Communications Ltd. provides a range of communications services in Israel. It offers a range of telecommunications operations and services, including local fixed-line, cellular, Internet, international communication, multi-channel television, satellite broadcasting, and customer call center.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (CLNO.OB).